DIGITAL EDITION

ARCHIVES

Category: Current Issue

Innovative Technologies in CNS Trials: Promises and Pitfalls for Recruitment, Retention, and Representativeness

by Jacqueline Lutz, PhD; Abhishek Pratap, PhD; Eric J. Lenze, MD; Durga Bestha, MD; Jessica M. Lipschitz, PhD; Stella Karantzoulis, PhD; Uma Vaidyanathan, PhD; Jessica Robin, PhD; William Horan, PhD;

Exploring the Complex Relationship Between Antiepileptic Drugs and Suicidality: A Systematic Literature Review

by Aksha M. Memon, MBBS, MD, MPH; Jigar Katwala, MBBS, MD; Clarice Douille, BS; Caitlin Kelley, BS; and Varun Monga, MD Dr. Memon is with Creighton University School of Medicine

Risk Management: Treating Patients at Risk for Suicide: Part 2

by Akemini “Kem” Isang, RN, JD Ms. Isang is a Risk Manager at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article. Disclosures:

Letter to the Editor: Olanzapine-induced Endoplasmic Reticulum Stress Induces Atypical Diabetes and Diabetic Ketoacidosis

Funding/financial disclosures. The author has no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2022;19(10–12):8–9.

Major Depressive Disorder, Suicides, and the Role of Dimensional Psychiatry for Triaging in Primary Care Settings: A Case Series Retroanalysis

by Atmaram Yarlagadda, MD; Adrian R. Johnson, LCSW, MSW; Cheyenne M. Bickerstaff, BS; Joseph R. Yancey, MD, MBA; Samuel L. Preston, DO; Liquori L. Etheridge, LCSW; Michelle Maddalozzo, LCSW; Samuel

Executive Functioning in Children and Adolescents with ADHD and Disruptive Behavior Disorders

by Rosa Elena Ulloa Flores, MD, PhD; Ricardo Díaz Sánchez, BS; Francisco R. de la Peña, MD, MS; Marcos F. Rosetti Sciutto, PhD; Lino Palacios Cruz, MD, PhD; and Pablo

Olfactory Dysfunction in Incidental Lewy Body Disease and Parkinson’s Disease: An Update

by Shemonti Hasan, MD; Charles H. Adler, MD, PhD; Nan Zhang, MS; Geidy E. Serrano, PhD; Lucia I. Sue, BS; Holly A. Shill, MD; Shyamal H. Mehta, MD, PhD; Thomas

Impact of COVID-19 Pandemic on Psychiatric Patients at Clinical Trial Sites

by Maria Fe Garcia-Rada, MPS, and Robert E. Litman, MD Ms. Garcia-Rada and Dr. Litman are with CenExel CBH Health in Gaithersburg, Maryland. Dr. Litman is with Georgetown University Medical

Stroop Test for Parkinson’s Disease with Deep Brain Stimulation: A Systematic Review

by Amer Cavalheiro Hamdan, PhD, and Mariana Drabik Vieira, MSc Dr. Hamdan is with the Graduate Program in Psychology, Department of Psychology, Federal University of Parana in Curitiba, Brazil. Dr.

Psychotherapy for Adult ADHD

by Kari Harper, MD, and Julie P. Gentile, MD, MBA Dr. Harper is Assistant Professor and Dr. Gentile is Professor and Chair of the Department of Psychiatry at Wright State

Play Therapy via Telemedicine in a Child with Sudden-onset Emotional Disorder During the COVID-19 Lockdown Period: A Case Report

by Swapnajeet Sahoo, MD; Diksha Sachdeva, MPhil; Sana Yumnam, MD; Ruchita Shah, MD; Aseem Mehra, MD; and Sandeep Grover, MD All authors are with the Department of Psychiatry, Post Graduate

Virtual and Augmented Reality-based Treatments for Phantom Limb Pain: A Systematic Review

by Andrew Yimu Vassantachart, MD; Elizabeth Yeo, MD; and Brian Chau, MD Dr. Vassantachart is with Loma Linda University School of Medicine in Loma Linda, California. Dr. Yeo is with

Risk Management: Top 25 Tips to Reduce Clinicians’ Stress Levels

by Donna Vanderpool, MBA, JD Ms. Vanderpool is the Director of Risk Management at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article.

Letter to the Editor: Steroid Management in a Patient with Myasthenia Gravis Undergoing COVID-19 Vaccination

Funding/financial disclosures. The authors have no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2022;19(7–9):8.